News

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a strategic alliance with the Inherited Neuropathy Consortium The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments to patients, today ...

Exciting news from a CMTA-STAR-funded research project has been published by Jordan VerPlank, PhD, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the Uniformed Services University of the Health Sciences (USU). The paper, published in Cellular and ...

In a jointly-funded project between CMTA and the Muscular Dystrophy Association (MDA), Alexia Kagiava, PhD, and her team at the Cyprus Institute of Neurology and Genetics in Cyprus are pioneering the use of nanoparticles to deliver gene therapies directly ...

CMTA is excited to report significant progress in its strategic CMTA-STAR investment of over $200,000 towards developing a human-derived organoid model for CMT1A. This pioneering research led by Professor Vincent Timmerman, PhD, at the University of Antwerp in Antwerp, Belgium, ...

With the incredible support of the CMT community, Esther Wolfs, PhD, and her team at FIERCE Lab located at Hasselt University in Belgium have made tremendous progress in their groundbreaking research to develop a new model for CMT1A using dental ...